FIELD: medicine; neurology.
SUBSTANCE: invention concerns treatment methods for neurodegenerative brain condition, such as Parkinson' and Alzheimer's disease, and methods of nerve cells death and degeneration. A therapeutically effective quantity of the composition containing brimonidin or its pharmaceutically acceptable salt is administered to a mammal.
EFFECT: treatment or prevention of nerve cells degeneration due to neuroprotective effect of brimonidin in respect of brain neurons.
6 cl, 1 ex, 1 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGONISTS OF ALPHA-2B OR 2B/2C ADRENORECEPTORS FOR NEURODEGENERATIVE DISEASES TREATMENT | 2003 |
|
RU2330649C2 |
| AGENT WITH ANTIAPOPTOTIC ACTIVITY | 2018 |
|
RU2685428C1 |
| METHOD FOR SCREENING PRO- OR ANTIAPOPTOGENOUS ACTIVITY OF THERAPEUTIC PREPARATIONS | 2008 |
|
RU2388065C1 |
| USE OF HSP70 AS ENZYME ACTIVITY REGULATOR | 2009 |
|
RU2571946C2 |
| DERIVATIVES OF 5B-SAPOGENIN AND PSEUDO SAPOGENIN AND APPLICATION FOR DEMENTIA MEDICAL TREATMENT | 2000 |
|
RU2325396C2 |
| APPLICATION OF ANTIBODY AGAINST AMYLOID-BETA IN CASE OF EYE DISEASES | 2008 |
|
RU2571859C2 |
| USING OPIOIDS OR OPIOID MIMETICS FOR TREATING PATIENTS WITH PERSISTENT MALIGNANT TUMOUR | 2009 |
|
RU2520636C2 |
| APPLICATION OF HSP70 AS REGULATOR OF ENZYMATIC ACTIVITY | 2009 |
|
RU2521672C2 |
| GENE TRANSITION MEDIATED BY LENTIVIRAL VECTOR AND METHOD FOR USING THE GENES | 2001 |
|
RU2288742C2 |
| AGONISTS OF NEUROTROPHIN RECEPTORS AND THEIR USE AS MEDICAMENTS | 2011 |
|
RU2606622C2 |
